Demand for Contrast Media Injectors and Impact of COVID-19……..


The global contrast media injectors market size is expected to reach USD 1.4 billion by 2025, growing at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive surgical procedures is a major factor expected to boost the market during the forecast period. These devices assist surgeons in accurate insertion of contrast agents with reduced human errors, thus increasing the accuracy and efficiency of surgical procedures. They play a crucial role in Intraoperative Computed Tomography (iCT), Intraoperative Magnetic Resonance Imaging (iMRI), and interventional cardiology. Availability of advanced injector systems for diagnosis and intraoperative imaging has boosted adoption of these systems. For instance, Medrad Stellant CT injection system integrated with Certegra Workstation provides high efficiency and accuracy in CT imaging.
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
Technological advancements, such as automated contrast media injectors and double-head injectors, are also among major factors supporting the growth of the market. Automated contrast media injectors provide improved patient safety, accuracy, and enhance image quality. Also, double-head injectors allow a large and rapid initial bolus of contrast, which is required in several imaging procedures. For instance, in cardiac CT, a fast injection is required for imaging of both sides of the ventricular septum to identify septal thickness, shunts, and enlarged ventricles. Delivery of contrast media is more efficient and controlled with a dual-head injector.
The global contrast media injectors market size was estimated at USD 882.1 million in 2016. Technological advancements and increasing demand for minimally invasive surgeries are some of the major factors contributing to the market growth.
To Request Sample Copy of this report, click the link:
Further Key Findings From the Report Suggest:
·         CT injector systems segment was the largest revenue-generating segment of the market in 2016 owing to availability of technologically advanced products and their widespread application for disease diagnosis and image-guided surgeries
·         The single head injectors segment accounted for the largest revenue share in 2016 and is expected to maintain its dominance throughout the study period
·         In the application segment, interventional cardiology is projected grow at the highest rate during the forecast period because of rising prevalence of cardiac diseases, such as coronary artery disease, heart valve disease, and peripheral vascular disease
·         In 2016, hospitals dominated the market in terms of revenue because of an increase in the number of hospital admissions of patients suffering from cancer, neurological disorders, and cardiovascular diseases
·         The North America contrast media injectors market held the largest revenue share in 2016 and is projected to maintain its dominance during the forecast period owing to well-established healthcare infrastructure
·         Some of the major players are Bayer HealthCare LLC; Guerbet Group; Bracco Group; Medtron AG; GE Healthcare; Nemoto Kyorindo Co., Ltd.; Ulrich GmbH & Co. KG; VIVID IMAGING; Sino Medical-Device Technology Co., Ltd.; and APOLLO RT Co. Ltd.

Technological advancements in the field of contrast media injectors, including IT-enabled solutions for syringeless, dual-head, and automated injectors, have brought about incremental changes in medical imaging. Syringeless injectors are more user-friendly, efficient, minimize contrast agent wastage, and provide contrast enhancement during imaging. For instance, in November 2016, Bracco Group launched a new syringeless injector CT Exprès 3D Contrast Media Delivery System in the U.S. This system provides several advantages, such as doing away with the need to fill and clean syringes, user-friendliness, and high efficiency.
Minimally invasive surgical procedures provide various advantages, such as smaller incisions, rapid wound healing, shorter hospital stays, less pain, and minor surgical wounds. Minimally invasive surgical procedures with contrast media injectors deliver high quality real-time imaging of the surgical site, and ensure that surgeons are treating the appropriate area. Thus, adoption of these products for minimally invasive surgeries is rising gradually, and this is expected to fuel growth.
Increase in prevalence of several chronic diseases, such as cancer, as well as cardiac, neurological, and orthopedic diseases, is expected to boost the market. According to American Cancer Society, around 1,688,780 new cancer cases are estimated to be diagnosed in 2017 in the U.S. Furthermore, according to CDC, 28.4 million adults were diagnosed with heart disease in the U.S. in 2015. Thus, there is growing demand for advanced products for diagnosis and treatment of chronic diseases, which is projected to drive growth.
Browse Press Release of this report:                                                                  
Grand View Research has segmented the global contrast media injectors market on the basis of product, type, application, end use, and region:
Contrast Media Injectors Product Outlook (Revenue, USD Million; 2014 - 2025)
·         Injector Systems
o    CT injector systems
o    MRI injector systems
o    Cardiovascular/angiography injector systems
·         Consumables
o    Tubing
o    Syringe
o    Others
Contrast Media Injectors Type Outlook (Revenue, USD Million; 2014 - 2025)
·         Single Head Injectors
·         Dual-Head Injectors
·         Syringeless Injectors
Contrast Media Injectors Application Outlook (Revenue, USD Million; 2014 - 2025)
·         Radiology
·         Interventional Cardiology
·         Interventional Radiology
Contrast Media Injectors End-Use Outlook (Revenue, USD Million; 2014 - 2025)
·         Hospitals
·         Diagnostics Centers
·         Ambulatory Surgery Centers
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.



Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..